Type 1 diabetes is a lifelong autoimmune condition where the body’s immune system attacks insulin-producing cells in the pancreas.

Patients rely on insulin therapy, but stem cell therapy in Turkey is providing new hope for long-term management and improved outcomes. Understanding Type 1 Diabetes Unlike type 2 diabetes, type 1 diabetes is not linked to lifestyle factors. It usually develops in childhood or adolescence but can also occur in adults.

The absence of insulin causes high blood sugar levels and long-term health complications. How Stem Cell Therapy Works Stem cell therapy aims to restore insulin production by regenerating pancreatic beta cells. Mesenchymal stem cells also have immune-modulating effects, helping reduce the autoimmune attack on these cells.

Benefits of Stem Cell Therapy in Turkey Turkey offers advanced stem cell facilities, experienced specialists, and affordable costs compared to the US and Europe. Patients also benefit from medical tourism services including personalized care and travel assistance. Candidate Eligibility Candidates include patients with early-stage type 1 diabetes or those who have difficulty controlling blood sugar despite insulin therapy.

Doctors conduct detailed evaluations before recommending treatment. Future Perspectives Ongoing research is promising, with the potential for stem cell therapy to significantly improve insulin independence in type 1 diabetes patients. Turkey continues to be a hub for clinical advancements in regenerative medicine.